North America Homeopathy Market Forecast to 2030 - Regional Analysis - by Source, Type, Application, and Distribution Channel

List of Tables

The North America homeopathy market was valued at US$ 1,648.42 million in 2022 and is expected to reach US$ 5,066.80 million by 2030; it is estimated to grow at a CAGR of 15.1% from 2022 to 2030.

Rise in Adoption of Homeopathic Medicine fuel the North America Homeopathy Market

There are growing concerns about the potential side effects of allopathic pharmaceutical drugs or regular medication. A study published in the Scandinavian Journal of Public Health in 2017 stated that alternative practices are primarily used in a complementary manner or in combination with traditional medicine.

The preference for orally administered medications and drugs without any side effects has been on the rise for a long, and it would continue to grow in the coming years. Allopathy contains strong medications; however, they are not appropriate for everyone. Furthermore, allopathic drugs are expensive and only have a transient effect on illnesses. Moreover, despite the completion of the course of prescribed drugs, the illness can resurface. Cases of drug abuse are more common with allopathic medicines, which is another factor for the shifting focus toward natural medications. Homeopathy remedies, on the other hand, are inexpensive and exhibit no or negligible side effects. Thus, the increasing adoption of homeopathic medicine bolsters the homeopathy market growth.

North America Homeopathy Market Overview

The North America homeopathy market has been segmented into the US, Canada, and Mexico; the US held the largest market share in 2022. The market growth in North America is attributed to the increased consumer awareness and interest in homeopathic remedies have played a significant role in the market growth, consumers are actively seeking alternative healthcare options and are more willing to explorer homeopathic treatment contributing to the market's expansion.

North America Homeopathy Market Revenue and Forecast to 2030 (US$ Million)

North America Homeopathy Market Segmentation

The North America homeopathy market is segmented based on source, type, application, distribution channel, and country. Based on source, the North America homeopathy market is segmented into plants, animals, and minerals. The plants segment held the largest market share in 2022.

Based on type, the North America homeopathy market is segmented into dilutions, tinctures, biochemics, ointments, tablets, and others. The dilutions segment held the largest market share in 2022.

Based on application, the North America homeopathy market is segmented into analgesic and antipyretic, respiratory, neurology, immunology, gastroenterology, dermatology, and others. The immunology segment held the largest market share in 2022.

Based on distribution channel, the North America homeopathy market is segmented into homeopathic clinics, retail pharmacies, e-retailers, and others. The homeopathic clinics segment held the largest market share in 2022.

Based on country, the North America homeopathy market is segmented into the US, Canada, and Mexico. The US dominated the North America homeopathy market share in 2022.

Fourrts; Hahnemann Laboratories, Inc; Boiron; Homeocan Inc; Hyland's, Inc.; Biologische Heilmittel Heel GmbH; DHU-Arzneimittel GmbH & Co. KG; Dr Reckeweg & Co GmbH; and Similasan Corp are some of the leading players operating in the North America homeopathy market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America homeopathy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America homeopathy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America homeopathy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00024765

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Homeopathy Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Safety Associated with Homeopathic Products
- 4.1.2 Rise in Adoption of Homeopathic Medicine
4.2 Market Restraints
- 4.2.1 Stringent Approach by Regulatory Authorities and Shortage of Homeopathic Facilities & Doctors
4.3 Market Opportunities
- 4.3.1 Rising awareness on Homeopathy Usage in Canada
4.4 Future Trends
- 4.4.1 Increasing Demand for Plant-Based Supplements and Launch of Innovative Homeopathic Remedies
4.5 Impact Analysis

5. Homeopathy Market - North America Market Analysis

5.1 Homeopathy Market Revenue (US$ Mn), 2022 - 2030

6. North America Homeopathy Market - Revenue and Forecast to 2030 - by Source

6.1 Overview
6.2 Homeopathy Market Revenue Share, by Source 2022 & 2030 (%)
6.3 Plants
- 6.3.1 Overview
- 6.3.2 Plants: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Animals
- 6.4.1 Overview
- 6.4.2 Animals: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Minerals
- 6.5.1 Overview
- 6.5.2 Minerals: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Homeopathy Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Homeopathy Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Dilutions
- 7.3.1 Overview
- 7.3.2 Dilutions: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Tinctures
- 7.4.1 Overview
- 7.4.2 Tinctures: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Biochemics
- 7.5.1 Overview
- 7.5.2 Biochemics: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Ointments
- 7.6.1 Overview
- 7.6.2 Ointments: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Tablets
- 7.7.1 Overview
- 7.7.2 Tablets: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Homeopathy Market - Revenue and Forecast to 2030 - by Application.

8.1 Overview
8.2 Homeopathy Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Analgesic and Antipyretic
- 8.3.1 Overview
- 8.3.2 Analgesic and Antipyretic: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Respiratory
- 8.4.1 Overview
- 8.4.2 Respiratory: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
- 8.5.1 Overview
- 8.5.2 Neurology: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Immunology
- 8.6.1 Overview
- 8.6.2 Immunology: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Gastroenterology
- 8.7.1 Overview
- 8.7.2 Gastroenterology: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Dermatology
- 8.8.1 Overview
- 8.8.2 Dermatology: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Homeopathy Market - Revenue and Forecast to 2030 - by Distribution Channel

9.1 Overview
9.2 Homeopathy Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Homeopathic Clinics
- 9.3.1 Overview
- 9.3.2 Homeopathic Clinics: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 e-Retailers
- 9.5.1 Overview
- 9.5.2 e-Retailers: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Homeopathy Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America: Homeopathy Market
- 10.1.1 Overview
- 10.1.2 North America: Homeopathy Market, by Country
  - 10.1.2.1 US: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 US: Homeopathy Market, by Source, 2020-2030 (US$ Million)
    - 10.1.2.1.4 US: Homeopathy Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.5 US: Homeopathy Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.6 US: Homeopathy Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 10.1.2.2 Canada: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 Canada: Homeopathy Market, by Source, 2020-2030 (US$ Million)
    - 10.1.2.2.4 Canada: Homeopathy Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.5 Canada: Homeopathy Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.6 Canada: Homeopathy Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 10.1.2.3 Mexico: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Homeopathy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 Mexico: Homeopathy Market, by Source, 2020-2030 (US$ Million)
    - 10.1.2.3.4 Mexico: Homeopathy Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.5 Mexico: Homeopathy Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.6 Mexico: Homeopathy Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Homeopathy Market-Industry Landscape

11.1 Overview
11.2 Organic Developments
- 11.2.1 Overview
11.3 Inorganic Developments
- 11.3.1 Overview

12. Company Profiles

12.1 Fourrts
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hahnemann Laboratories, Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boiron
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Homeocan Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Hyland's, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Biologische Heilmittel Heel GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 DHU-Arzneimittel GmbH & Co. KG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Dr Reckeweg & Co GmbH
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Similasan Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 Appendix
13.2 Appendix
13.3 Appendix
13.4 Glossary of Terms